Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: BDR who wrote (4227)	7/10/1998 8:49:00 PM
From: Anthony Wong	Respond to of 9523

Dale, perhaps like Tuna, he expects PFE to correct to $60 before it goes back up to $120 12 months later.

To: BDR who wrote (4227)	7/10/1998 9:26:00 PM
From: Anthony Wong	Read Replies (2) \| Respond to of 9523

Summary of analyst ratings issued on PFE today: ''buy'' by analyst Christina Heuer at Salomon Smith Barney, target price $155.00 ''strong buy'' by analyst David F. Saks at Gruntal & Co., target price $148.00 ''buy'' by analyst Cynthia A. Beach at Gerard Klauer Mattison, target price $140.00 ''buy'' by analyst Jerome R. Brimeyer at Warburg Dillon Read Inc target price $135.00 ''buy'' by analyst Leonard S. Yaffe Md at NationsBanc Montgomery Sec., target price $132.00 ''buy'' by analyst Carl J. Seiden at J.P. Morgan Securities, target price $131.00 near-term and long-term ''buy'' by analyst Steven C. Tighe at Merrill Lynch, no target price provided ''buy'' by analyst Kenneth R. Nover at A.G. Edwards, no target price provided ''attractive'' by analyst Jeffrey Chaffkin at PaineWebber Inc. target price $130.00 ''outperform'' by analyst Jami Rubin at Schroder & Co. , target price $130.00 ''outperform'' by analyst Paul A. Brooke at Morgan Stanley Dean Witter., target price $120.00 Note: 1) Target price - for 12 months, per share basis. 2) All are reiterations of old ratings, no upgrades or downgrrades.

To: BDR who wrote (4227)	7/10/1998 9:33:00 PM
From: chukles	Read Replies (1) \| Respond to of 9523

Having been happily employeed at Pfizer for the past 15 years, the bottom line is this. Pfizer will be 150 years old next year. The ultimate goal of Bill Steere is to have satisfied shareholders and a stock price of 150 coupled with a three for one split is his objective. Continued share buybacks coupled with the number one sales force in this industry will almost guarantee that. I have every option granted as an employee, and the ones at $6.00 keep me smiling. This thread is pretty informed and I have seen at times some inside info and I am posting this just to thank everyone for the outside perspective I receive on this innovative and very aggressive company.